Treating cancer with genetically engineered T cells
- 9 June 2011
- journal article
- review article
- Published by Elsevier BV in Trends in Biotechnology
- Vol. 29 (11), 550-557
- https://doi.org/10.1016/j.tibtech.2011.04.009
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- CARs on Track in the ClinicMolecular Therapy, 2011
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient ColitisMolecular Therapy, 2011
- Of Mice, Not Men: No Evidence for Graft-versus-Host Disease in Humans Receiving T-Cell Receptor–Transduced Autologous T CellsMolecular Therapy, 2010
- Advances in the Field of Lentivector-based Transduction of T and B Lymphocytes for Gene TherapyMolecular Therapy, 2010
- Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionCancer Immunology, Immunotherapy, 2010
- Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical TrialMolecular Therapy, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- A Transposon and Transposase System for Human ApplicationMolecular Therapy, 2010
- Adoptive T cell therapy of cancerCurrent Opinion in Immunology, 2010
- Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptorNature Medicine, 2008